Stock Events

Stock Events

Silence Therapeutics (SLN) Q1 2025 Earnings

27FebConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-0.09

-0.05

-0.01

0.02

Details

Expected EPS

-0.0705407713

Actual EPS

0.0231165747

Surprise EPS

0.09

Surprise Percent

+132.77%

Description

Silence Therapeutics (SLN) has reported earnings of 0.0231165747 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.